Cargando…
Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders
Post-transplant lymphoproliferative disorder (PTLD) and other iatrogenic immunodeficiency-associated lymphoproliferative disorders (OIIA-LPD) are iatrogenic lymphoproliferative disorders (LPD) that develop in association with immunosuppressive treatment in the setting of organ transplantation and au...
Autores principales: | Kabasawa, Nobuyuki, Shiozawa, Eisuke, Murai, So, Homma, Mayumi, Uesugi, Yuka, Matsui, Tomoharu, Nakata, Ayaka, Shimada, Shotaro, Sasaki, Yohei, Baba, Yuta, Watanuki, Megumi, Arai, Nana, Fujiwara, Shun, Kawaguchi, Yukiko, Tsukamoto, Hiroyuki, Uto, Yui, Yanagisawa, Kouji, Hattori, Norimichi, Sakai, Hirotaka, Harada, Hiroshi, Nakamaki, Tsuyoshi, Takimoto, Masafumi, Yamochi-Onizuka, Toshiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JSLRT
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519242/ https://www.ncbi.nlm.nih.gov/pubmed/34511544 http://dx.doi.org/10.3960/jslrt.20025 |
Ejemplares similares
-
The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential
por: Dal Bo, Michele, et al.
Publicado: (2015) -
C-myc and N-myc in the developing brain
por: Wey, Alice, et al.
Publicado: (2010) -
MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
por: Nwanze, Julum, et al.
Publicado: (2017) -
The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020) -
Natural Killer Immunotherapy for Minimal Residual Disease Eradication Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
por: Hattori, Norimichi, et al.
Publicado: (2019)